Show simple item record

dc.contributor.authorScheel, Christina
dc.contributor.authorWeinberg, Robert A
dc.date.accessioned2018-07-13T13:20:43Z
dc.date.available2018-07-13T13:20:43Z
dc.date.issued2011-07
dc.date.submitted2010-12
dc.identifier.issn0020-7136
dc.identifier.issn1097-0215
dc.identifier.urihttp://hdl.handle.net/1721.1/116967
dc.description.abstractCancer stem cells (CSCs) are similar to normal stem cells in their ability to self-renew and to generate large populations of more differentiated descendants. In contrast to the hierarchical organization that is presumed to be the prevalent mode of normal tissue homeostasis, phenotypic plasticity allows cancer cells to dynamically enter into and exit from stem-cell states. The epithelial-mesenchymal transition (EMT) has been closely associated with the acquisition of both invasive and stem-cell properties in cancer cells. Thereby, EMT programs emerge as important regulators of phenotypic plasticity in cancer cells including their entrance into stem-cell states. Much is still to be learned about the regulation of EMTs through epigenetic mechanisms in cancer cells and the contributions that EMT programs make to normal tissue homeostasis.en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant CA12515)en_US
dc.description.sponsorshipNational Cancer Institute (U.S.) (Grant CA12515)en_US
dc.description.sponsorshipNational Institutes of Health (U.S.) (Grant DE020817)en_US
dc.description.sponsorshipNational Cancer Institute (U.S.) (Grant DE020817)en_US
dc.publisherWiley Blackwellen_US
dc.relation.isversionofhttp://dx.doi.org/10.1002/ijc.26311en_US
dc.rightsCreative Commons Attribution-Noncommercial-Share Alikeen_US
dc.rights.urihttp://creativecommons.org/licenses/by-nc-sa/4.0/en_US
dc.sourcePMCen_US
dc.titlePhenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells?en_US
dc.typeArticleen_US
dc.identifier.citationScheel, Christina, and Robert A. Weinberg. “Phenotypic Plasticity and Epithelial-Mesenchymal Transitions in Cancer and Normal Stem Cells?” International Journal of Cancer 129, no. 10 (August 29, 2011): 2310–2314 © 2011 UICCen_US
dc.contributor.departmentMassachusetts Institute of Technology. Department of Biologyen_US
dc.contributor.departmentLudwig Center for Molecular Oncology (Massachusetts Institute of Technology)en_US
dc.contributor.mitauthorWeinberg, Robert A
dc.relation.journalInternational Journal of Canceren_US
dc.eprint.versionAuthor's final manuscripten_US
dc.type.urihttp://purl.org/eprint/type/JournalArticleen_US
eprint.statushttp://purl.org/eprint/status/PeerRevieweden_US
dc.date.updated2018-07-12T17:43:25Z
dspace.orderedauthorsScheel, Christina; Weinberg, Robert A.en_US
dspace.embargo.termsNen_US
dc.identifier.orcidhttps://orcid.org/0000-0002-0895-3557
mit.licenseOPEN_ACCESS_POLICYen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record